X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (827) 827
Paper (324) 324
Publication (221) 221
Report (180) 180
Patent (24) 24
Newspaper Article (18) 18
Book / eBook (8) 8
Magazine Article (7) 7
Conference Proceeding (6) 6
Data Set (5) 5
Book Chapter (4) 4
Book Review (3) 3
Web Resource (2) 2
Government Document (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
cern lhc coll (583) 583
experimental results (579) 579
p p: scattering (465) 465
p p: colliding beams (431) 431
cms (397) 397
experiment (372) 372
physics (369) 369
13000 gev-cms (367) 367
high energy physics - experiment (344) 344
particle physics (311) 311
physics - high energy physics - experiment (299) 299
high energy physics (296) 296
hep (216) 216
phenomenology (214) 214
physics of elementary particles and fields (186) 186
scattering [p p] (181) 181
background (180) 180
colliding beams [p p] (171) 171
8000 gev-cms (130) 130
ex (118) 118
nuclear experiment (116) 116
hadron-hadron scattering (114) 114
transverse momentum: missing-energy (103) 103
channel cross section: upper limit (101) 101
index medicus (96) 96
humans (94) 94
cern lab (89) 89
supersymmetry (89) 89
[phys.hexp]physics [physics]/high energy physics - experiment [hep-ex] (86) 86
mass dependence (86) 86
final state:jet lepton (85) 85
female (76) 76
male (74) 74
bottom: particle identification (69) 69
[ phys.hexp ] physics [physics]/high energy physics - experiment [hep-ex] (67) 67
top: pair production (67) 67
transverse momentum dependence (67) 67
jet: bottom (65) 65
kinematics (65) 65
data analysis method (64) 64
z0: leptonic decay (62) 62
channel cross section: branching ratio: upper limit (60) 60
muon: pair production (60) 60
final state:jet dilepton (58) 58
higgs particle: hadroproduction (55) 55
particle physics - experiment (55) 55
channel cross section: measured (54) 54
114 physical sciences (53) 53
quantum chromodynamics: perturbation theory (51) 51
mass spectrum: (50) 50
rapidity dependence (50) 50
astrophysics (49) 49
bottom: pair production (48) 48
child (48) 48
clinical neurology (48) 48
electroweak interaction (47) 47
w: leptonic decay (46) 46
transverse momentum (45) 45
squark: pair production (44) 44
upper limit [channel cross section] (43) 43
adolescent (42) 42
differential cross section: measured (42) 42
lead (42) 42
mass: lower limit (42) 42
beyond standard model (41) 41
sensitivity (41) 41
final state:jet (40) 40
physics, particles & fields (40) 40
jet: transverse momentum (39) 39
narrow resonance (39) 39
jet lepton (38) 38
nuclear physics (38) 38
gravitation (37) 37
new physics: search for (37) 37
structure (37) 37
higgs particle: hadronic decay (36) 36
missing-energy [transverse momentum] (36) 36
numerical calculations: monte carlo (36) 36
tau: pair production (36) 36
resonance: production (35) 35
z0: associated production (34) 34
epilepsy (33) 33
high energy astrophysical phenomena (33) 33
rapidity (33) 33
stop: mass: lower limit (33) 33
dijet (32) 32
higher-order: 1 (32) 32
nuclear and particle physics. atomic energy. radioactivity (31) 31
signature (31) 31
adult (30) 30
children (30) 30
gluino: mass: lower limit (30) 30
hep-ex (30) 30
jet: multiplicity (30) 30
gluino: pair production (29) 29
phase space (29) 29
seizures (29) 29
child, preschool (28) 28
perturbation theory: higher-order (28) 28
new particle (27) 27
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1079) 1079
French (9) 9
German (7) 7
Chinese (3) 3
Portuguese (2) 2
Panjabi (1) 1
Spanish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Developmental Medicine & Child Neurology, ISSN 0012-1622, 01/2019, Volume 61, Issue 1, pp. 9 - 10
This commentary is on the original article by Sartori et al. on pages 82–90 of this issue. 
PEDIATRICS | CLINICAL NEUROLOGY | EPILEPSY | Recurrence | Emergency Service, Hospital | Epilepsy | Humans | Risk Factors | Child | Seizures
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 05/2015, Volume 372, Issue 19, pp. 1791 - 1800
Patients with myocardial infarction 1 to 3 years previously were assigned to ticagrelor, 90 or 60 mg twice daily, or to placebo, in addition to low-dose... 
MEDICINE, GENERAL & INTERNAL | HEART-DISEASE | CLOPIDOGREL | MANAGEMENT | ESC GUIDELINES | AMERICAN-COLLEGE | PREVENTION | ASSOCIATION TASK-FORCE | ACUTE CORONARY SYNDROMES | PRASUGREL | ASPIRIN | Purinergic P2Y Receptor Antagonists - administration & dosage | Double-Blind Method | Drug Administration Schedule | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Kaplan-Meier Estimate | Male | Risk | Secondary Prevention | Adenosine - administration & dosage | Aspirin - administration & dosage | Purinergic P2Y Receptor Antagonists - adverse effects | Myocardial Infarction - drug therapy | Adenosine - adverse effects | Adenosine - analogs & derivatives | Intracranial Hemorrhages - chemically induced | Platelet Aggregation Inhibitors - administration & dosage | Cardiovascular Diseases - mortality | Female | Aged | Hemorrhage - chemically induced | Drug Therapy, Combination | Platelet Aggregation Inhibitors - adverse effects | Dose-response relationship (Biochemistry) | Treatment outcome | Care and treatment | Safety and security measures | Analysis | Dosage and administration | Ticagrelor | Heart attack | Risk factors | Myocardial infarction | Cerebral infarction | Aspirin | Stroke | Heart attacks | Hemorrhage | Long term | Patients | Thrombolysis | Bleeding | Blood platelets | Antagonist drugs | Cardiovascular diseases | Drug therapy | Life Sciences | Human health and pathology
Journal Article
Epilepsia, ISSN 0013-9580, 07/2016, Volume 57, Issue 7, pp. 1053 - 1068
Journal Article
by Abarca-Gómez, Leandra and Abdeen, Ziad A and Hamid, Zargar Abdul and Abu-Rmeileh, Niveen M and Acosta-Cazares, Benjamin and Acuin, Cecilia and Adams, Robert J and Aekplakorn, Wichai and Afsana, Kaosar and Aguilar-Salinas, Carlos A and Agyemang, Charles and Ahmadvand, Alireza and Ahrens, Wolfgang and Ajlouni, Kamel and Akhtaeva, Nazgul and Al-Hazzaa, Hazzaa M and Al-Othman, Amani Rashed and Al-Raddadi, Rajaa and Al Buhairan, Fadia and Al Dhukair, Shahla and Ali, Osman and Ali, Mohamed M and Alkerwi, Ala'a and Alvarez-Pedrerol, Mar and Aly, Eman and Amarapurkar, Deepak N and Amouyel, Philippe and Amuzu, Antoinette and Andersen, Lars Bo and Anderssen, Sigmund A and Andrade, Dolores S and Ängquist, Lars H and Anjana, Ranjit Mohan and Aounallah-Skhiri, Hajer and Araújo, Joana and Ariansen, Inger and Aris, Tahir and Arlappa, Nimmathota and Arveiler, Dominique and Aryal, Krishna K and Aspelund, Thor and Assah, Felix K and Assunção, Maria Cecília F and Aung, May Soe and Avdicová, Mária and Azevedo, Ana and Azizi, Fereidoun and Babu, Bontha V and Bahijri, Suhad and Baker, Jennifer L and Balakrishna, Nagalla and Bamoshmoosh, Mohamed and Banach, Maciej and Bandosz, Piotr and Banegas, José R and Barbagallo, Carlo M and Barceló, Alberto and Barkat, Amina and Barros, Aluisio JD and Barros, Mauro VG and Bata, Iqbal and Batieha, Anwar M and Batista, Rosangela L and Batyrbek, Assembekov and Baur, Louise A and Beaglehole, Robert and Romdhane, Habiba Ben and Benedics, Judith and Benet, Mikhail and Bennett, James E and Bernabe-Ortiz, Antonio and Bernotiene, Gailute and Bettiol, Heloisa and Bhagyalaxmi, Aroor and Bharadwaj, Sumit and Bhargava, Santosh K and Bhatti, Zaid and Bhutta, Zulfiqar A and Bi, Hongsheng and Bi, Yufang and Biehl, Anna and Bikbov, Mukharram and Bista, Bihungum and Bjelica, Dusko J and Bjerregaard, Peter and Bjertness, Marius B and Bjertness, Espen and Björkelund, Cecilia and Blokstra, Anneke and Bo, Simona and Bobak, Martin and Boddy, Lynne M and Boehm, Bernhard O and Boeing, Heiner and Boggia, Jose G and Boissonnet, Carlos P and Bonaccio, Marialaura and Bongard, Vanina and Bovet, Pascal and Braeckevelt, Lien and ... and NCD Risk Factor Collaboration (NCD-RisC) and Högskolan Dalarna and Akademin Utbildning, hälsa och samhälle and Omvårdnad
The Lancet, ISSN 0140-6736, 12/2017, Volume 390, Issue 10113, pp. 2627 - 2642
Journal Article